Grüneberg and Myers turned the traditional law firm model on its head, to set a new standard for in-depth, personalized, cost-efficient patent counsel. Now in operation for over three years, the firm has grown into an all-star team, led by three partners with substantial experience in patent prosecution, appeals, litigation, post-grant proceedings, and counseling.
The firm is 100% women- and ethnic minority-owned, and includes diverse representation at all levels. Varied backgrounds strengthen the firm and provide wide-ranging perspectives.
Cost-Efficient High Quality
In an ever-changing market, Grüneberg and Myers offers cost savings for patent legal budgets. Because adaptations to modern business practices are difficult for traditional IP firms, Grüneberg and Myers started in 2017 to clean the slate and begin anew. With innovative office concepts and modern, high-tech law practice management systems, the firm reduced overhead, bringing prices to a very competitive level. Constantly-updated, state-of-the-art file and docket management software provide robust cybersecurity and increased efficiency, within a reasonable technology budget. A modern office concept encourages collaboration between team members.
The firm’s price-competitive and technically-savvy nature has enabled seamless adaptation and continued growth, even during the COVID-19 pandemic.
At the same time, the firm maintained high quality by recruiting experienced attorneys and staff. The firm itself was listed as a recommended patent prosecution firm in the Washington, DC area in IAM Patent 1000 after just a few years in business. Publications have also ranked some of the firm’s individual attorneys in LMG Life Sciences’ Life Sciences Stars, the IAM Strategy 300, the IAM Patent 1000, Managing IP’s IP Stars, and Thomson Reuters’s Super Lawyers. The team includes graduates from prestigious universities such as Cornell, Duke, Penn State, Johns Hopkins, George Mason University, and George Washington University, as well as a Lynen fellow of the Alexander von Humboldt Foundation. Team members have previously worked at the International Trade Commission, the Court of Appeals for the Federal Circuit, the U.S. Patent and Trademark Office, in-house positions, large general-practice firms, and IP boutiques.
The professionals include native German, Japanese and Korean speakers.
Experienced staff support the firm’s attorneys. While the firm itself started in 2017, the firm’s staff leadership has worked in managerial and supervisory roles in larger, high-volume patent prosecution firms and in-house at large companies, thus carrying forward decades of institutional knowledge in an innovative, efficient environment.
Life Sciences IP Strategy
Global pharmaceutical and life sciences companies trust Grüneberg and Myers with high-value, strategically-important intellectual property decisions. The firm has guided clients to optimal outcomes with Hatch-Waxman exclusivity, Patent Term Extension, Orange Book listings, Biologics Price Competition and Innovation Act strategy, and patent subject matter eligibility for diagnostics. Life sciences and pharmaceutical companies have relied on the firm’s life sciences expertise to provide counsel on licensing and post-grant matters with hundreds of millions of dollars or more at stake.
The attorneys at Grüneberg and Myers prepare and prosecute U.S. and international patent applications with skill and experience. Using the full menu of options available at the USPTO, including Examiner interviews, pilot programs, and accelerated examination, Grüneberg and Myers pursues optimized, strong patent protection for its clients. The firm prides itself on detailed analysis of office actions and other requirements with fast turnaround, avoiding the need for extensions and facilitating greater familiarity with cases, both for applicants and Examiners.
The firm also coordinates global patent prosecution and portfolio management. Often traveling and maintaining relationships with patent procurement firms globally, the attorneys at Grüneberg and Myers consolidate patent strategies and take the work off of in-house counsel.
With its low-overhead model, Grüneberg and Myers can prosecute applications within competitive alternative fee structures.
Post-Grant Proceedings, PTAB Appeals, Counseling, and Freedom-to-Operate
The attorneys at Grüneberg and Myers have years of experience with counseling, freedom-to-operate, PTAB appeals, and post-grant matters. In addition, the attorneys at Grüneberg and Myers have performed large product IP-clearance projects, and have helped clients to navigate complex strategies in patent subject matter eligibility. The attorneys of the firm have also achieved substantial positive outcomes for clients in reexamination and in inter partes review.
When in-house counsel needs to operate on a budget, the firm can provide predictable costs.
Large, global corporations, including Fortune 50 companies and Fortune Global 200 companies trust Grüneberg and Myers with important roles in building and maintaining patent portfolios and in operating in competitive IP environments. The firm serves major companies in Europe, Asia, and the Americas, supporting in-house counsel in biotechnology, chemical, pharmaceutical, medical devices, AI and machine learning, electronics, and tools and machinery industries.
Clients have expressed a high level of satisfaction with the firm’s procedural and substantive handling of their patent matters, as well as with the firm’s flexibility to offer competitive pricing.